Jump to main content
eTG Complete
Index
Search
Home
Palliative Care
Medication management in palliative care
Medication rationalisation in palliative care
Rationalising anticoagulants in palliative care
Palliative Care
What is covered in the Palliative Care guidelines?
Overview of palliative care
Communicating with and supporting patients with palliative care needs
Advance care planning
Decision-making and ethical challenges in palliative care
Family support in palliative care
Support for carers in palliative care
Healthcare professional wellbeing in palliative care
Loss, grief and bereavement
Principles of symptom management in palliative care
Emergencies in palliative care
Principles of paediatric palliative care
Principles of palliative care for patients with common life-limiting illnesses
Multimorbidity and frailty in palliative care
Disorders of substance use in palliative care
Desire to die in palliative care
Pain in palliative care
Fatigue in palliative care
Respiratory problems in palliative care
Gastrointestinal problems in palliative care
Emotional, psychological and behavioural symptoms in palliative care
Delirium in palliative care
Sleep disturbance in palliative care
Neurological and neuromuscular problems in palliative care
Dermatological problems in palliative care
Genitourinary problems in palliative care
Haematological problems in palliative care
Hypercalcaemia associated with cancer
Hyponatraemia in palliative care
Catastrophic terminal events in palliative care
Care in the last days of life
After-death care
Medication management in palliative care
Principles of medication management in palliative care
Routes of drug administration in palliative care
Pharmaceutical Benefits Scheme and palliative care
Off-label use of medications in palliative care
Medication rationalisation in palliative care
Principles of medication rationalisation in palliative care
Rationalising acetylcholinesterase inhibitors and memantine in palliative care
Rationalising anticoagulants in palliative care
Principles of rationalising anticoagulants in palliative care
Rationalising anticoagulants used for VTE treatment in palliative care
Rationalising anticoagulants used for VTE prophylaxis in palliative care
Rationalising anticoagulants used to prevent stroke or thromboembolism in palliative care
Considerations for warfarin use in palliative care
Rationalising antiepileptics used for seizures in palliative care
Rationalising antihyperglycaemic drugs in palliative care
Rationalising long-term antimicrobial therapy in palliative care
Rationalising antiplatelet drugs in palliative care
Rationalising bisphosphonates and denosumab in palliative care
Rationalising cardiovascular drugs in palliative care
Rationalising oral corticosteroids in palliative care
Rationalising disease-modifying drugs for progressive neurological diseases in palliative care
Rationalising immunosuppressants, immunotherapy and oral anticancer drugs in palliative care
Rationalising inhaled drugs in palliative care
Rationalising drugs for Parkinson disease in palliative care
Rationalising proton pump inhibitors in palliative care
Rationalising psychotropics in palliative care
Rationalising supportive therapies for chronic kidney disease in palliative care
Rationalising thyroid replacement therapy in palliative care
Rationalising vitamin and mineral supplements in palliative care
References
Opioid use in palliative care
Rationalising anticoagulants in palliative care
Principles of rationalising anticoagulants in palliative care
Rationalising anticoagulants used for VTE treatment in palliative care
Rationalising anticoagulants used for VTE prophylaxis in palliative care
Rationalising anticoagulants used to prevent stroke or thromboembolism in palliative care
Considerations for warfarin use in palliative care
